{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:44:40Z","timestamp":1775976280951,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00062","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T06:04:49Z","timestamp":1455084289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime"],"prefix":"10.3389","volume":"7","author":[{"given":"Jie","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Weitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"B1","first-page":"351","article-title":"Third-generation cephalosporins: a critical evaluation.","volume":"3","author":"Barriere","year":"1984","journal-title":"Clin. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.","volume":"122","author":"Bockenstedt","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1128\/AAC.00883-15","article-title":"Persister development by Borrelia burgdorferi populations in vitro.","volume":"59","author":"Caskey","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","author":"CDC","year":"2015a","journal-title":"Lyme Disease."},{"key":"B5","author":"CDC","year":"2015b","journal-title":"Post-Treatment Lyme Disease Syndrome."},{"key":"B6","first-page":"154","author":"Clinical and Laboratory Standards Institute [CLSI]","year":"2007","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17 27."},{"issue":"51","key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-51","article-title":"Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium.","volume":"4","author":"Dhillon","year":"2004","journal-title":"BMC Infect. Dis."},{"issue":"e29914","key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS ONE"},{"issue":"e0117207","key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117207","article-title":"Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.","volume":"10","author":"Feng","year":"2015a","journal-title":"PLoS ONE"},{"issue":"e31","key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.31","article-title":"Identification of new compounds with high activity against Borrelia burgdorferi persisters from the NCI compound collection.","volume":"4","author":"Feng","year":"2015b","journal-title":"Emerg. Microb. Infect."},{"issue":"e51","key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.56","article-title":"Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.","volume":"4","author":"Feng","year":"2015c","journal-title":"Emerg. Microb. Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics4030397","article-title":"Identification of additional anti-persister activity against Borrelia burgdorferi from an FDA drug library.","volume":"4","author":"Feng","year":"2015d","journal-title":"Antibiotics"},{"issue":"e49","key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.1053","article-title":"Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.","volume":"3","author":"Feng","year":"2014a","journal-title":"Emerg. Microb. Infect."},{"issue":"e111809","key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111809","article-title":"An optimized SYBR green I\/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi.","volume":"9","author":"Feng","year":"2014b","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice.","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"e86907","key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086907","article-title":"Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.","volume":"9","author":"Hodzic","year":"2014","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to Detect Borrelia burgdorferi Infection: a first-in-human study.","volume":"58","author":"Marques","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes.","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of lyme disease, forms drug-tolerant persister cells.","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/jaut.2000.0495","article-title":"Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.","volume":"16","author":"Steere","year":"2001","journal-title":"J. Autoimmun."},{"key":"B21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/JCM.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.","volume":"35","author":"Straubinger","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/CMR.00011-06","article-title":"Coinfections acquired from ixodes ticks.","volume":"19","author":"Swanson","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"e3","key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.3","article-title":"Persisters, persistent infections and the yin-yang model.","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microb. Infect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.06288-11","article-title":"Targeting persisters for tuberculosis control.","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:49:41Z","timestamp":1600148981000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00062\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00062","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}